1,517
Views
8
CrossRef citations to date
0
Altmetric
REVIEW

Disease Burden of Dysmenorrhea: Impact on Life Course Potential

, , , ORCID Icon &
Pages 499-509 | Received 30 Dec 2022, Accepted 13 Mar 2023, Published online: 03 Apr 2023

References

  • Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother. 2008;9(15):2661–2672. doi:10.1517/14656566.9.15.2661
  • Al-Jefout M, Nawaiseh N. Continuous norethisterone acetate versus cyclical drospirenone 3 mg/Ethinyl Estradiol 20 mug for the management of primary dysmenorrhea in young adult women. J Pediatr Adolesc Gynecol. 2016;29(2):143–147.
  • Armour M, Parry K, Manohar N, et al. The prevalence and academic impact of dysmenorrhea in 21,573 young women: a systematic review and meta-analysis. J Womens Health. 2019;28(8):1161–1171.
  • Akerlund M. Pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand Suppl. 1979;87:27–32.
  • Rosenwaks Z, Seegar-Jones G. Menstrual pain: its origin and pathogenesis. J Reprod Med. 1980;25(4 Suppl):207–212.
  • Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can. 2005;27(8):765–770.
  • Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6:177.
  • Ferries-Rowe E, Corey E, Archer JS. Primary Dysmenorrhea: diagnosis and Therapy. Obstet Gynecol. 2020;136(5):1047–1058.
  • Szmidt MK, Granda D, Sicinska E, Kaluza J. Primary dysmenorrhea in relation to oxidative stress and antioxidant status: a systematic review of case-control studies. Antioxidants. 2020;9(10):994.
  • Barcikowska Z, Rajkowska-Labon E, Grzybowska ME, Hansdorfer-Korzon R, Zorena K. Inflammatory markers in dysmenorrhea and therapeutic options. Int J Environ Res Public Health. 2020;17(4):1191. doi:10.3390/ijerph17041191
  • Oladosu FA, Tu FF, Hellman KM. Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol. 2018;218(4):390–400.
  • Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762–778.
  • Hellman KM, Kuhn CS, Tu FF, et al. Cine MRI during spontaneous cramps in women with menstrual pain. Am J Obstet Gynecol. 2018;218(5):506.e1–506.e8.
  • Bann S, Goshtasebi A, Shirin S, Prior JC. A one-year observational cohort study of menstrual cramps and ovulation in healthy, normally ovulating women. Sci Rep. 2022;12(1):473.
  • Vincent K, Warnaby C, Stagg CJ, Moore J, Kennedy S, Tracey I. Dysmenorrhoea is associated with central changes in otherwise healthy women. Pain. 2011;152(9):1966–1975.
  • Tu CH, Niddam DM, Yeh TC, et al. Menstrual pain is associated with rapid structural alterations in the brain. Pain. 2013;154(9):1718–1724.
  • Tu FF, Epstein AE, Pozolo KE, Sexton DL, Melnyk AI, Hellman KM. A noninvasive bladder sensory test supports a role for dysmenorrhea increasing bladder noxious mechanosensitivity. Clin J Pain. 2013;29(10):883–890.
  • Hellman KM, Datta A, Steiner ND, et al. Identification of experimental bladder sensitivity among dysmenorrhea sufferers. Am J Obstet Gynecol. 2018;219(1):84.e1–84.e8.
  • Tu FF, Datta A, Atashroo D, et al. Clinical profile of comorbid dysmenorrhea and bladder sensitivity: a cross-sectional analysis. Am J Obstet Gynecol. 2020;222(6):594.e1–594.e11.
  • Malykhina AP. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience. 2007;149(3):660–672.
  • Aouad P, Bui M, Sarraf S, et al. Primary dysmenorrhoea in adolescents and young women: a twin family study of maternal transmission, genetic influence and associations. Aust N Z J Obstet Gynaecol. 2022;62(5):725–731.
  • Li Z, Chen J, Zhao Y, et al. Common variants in ZMIZ1 and near NGF confer risk for primary dysmenorrhoea. Nat Commun. 2017;8:14900.
  • Burnett M, Lemyre M. No. 345-Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2017;39(7):585–595.
  • Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain. 2016;17(9 Suppl):T93–T107.
  • Jarrell J, Arendt-Nielsen L. Evolutionary considerations in the development of chronic pelvic pain. Am J Obstet Gynecol. 2016;215(2):201.e1–201.e2014.
  • Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332(7550):1134–1138.
  • Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;2015(7):CD001751.
  • Owen PR. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed. Am J Obstet Gynecol. 1984;148(1):96–103.
  • Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2011;95(6):1928–1931.
  • Edelman A, Micks E, Gallo MF, Jensen JT, Grimes DA. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;2014(7):CD004695.
  • Dmitrovic R, Kunselman AR, Legro RS. Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial. Obstet Gynecol. 2012;119(6):1143–1150.
  • Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol. 2002;186(6):1142–1149.
  • Bianchi P, Guo SW, Habiba M, Benagiano G. Utility of the levonorgestrel-releasing intrauterine system in the treatment of abnormal uterine bleeding and dysmenorrhea: a narrative review. J Clin Med. 2022;11(19):5836.
  • Bahamondes L, Petta CA, Fernandes A, Monteiro I. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception. 2007;75(6 Suppl):S134–S139.
  • Lindh I, Milsom I. The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study. Hum Reprod. 2013;28(7):1953–1960.
  • Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril. 2017;107(3):533–536.
  • Armour M, Ee CC, Naidoo D, et al. Exercise for dysmenorrhoea. Cochrane Database Syst Rev. 2019;9(9):CD004142.
  • Jo J, Lee SH. Heat therapy for primary dysmenorrhea: a systematic review and meta-analysis of its effects on pain relief and quality of life. Sci Rep. 2018;8(1):16252.
  • Elboim-Gabyzon M, Kalichman L. Transcutaneous Electrical Nerve Stimulation (TENS) for primary dysmenorrhea: an overview. Int J Womens Health. 2020;12:1–10.
  • Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016;3(3):CD002124.
  • Saei Ghare Naz M, Kiani Z, Rashidi FF, Ghasemi V, Abed M, Ozgoli G. The effect of micronutrients on pain management of primary dysmenorrhea: a systematic review and meta-analysis. J Caring Sci. 2020;9(1):47–56.
  • Rahnemaei FA, Gholamrezaei A, Afrakhteh M, et al. Vitamin D supplementation for primary dysmenorrhea: a double-blind, randomized, placebo-controlled trial. Obstet Gynecol Sci. 2021;64(4):353–363.
  • Abdi F, Amjadi MA, Zaheri F, Rahnemaei FA. Role of vitamin D and calcium in the relief of primary dysmenorrhea: a systematic review. Obstet Gynecol Sci. 2021;64(1):13–26.
  • Alikamali M, Mohammad-Alizadeh-Charandabi S, Maghalian M, Mirghafourvand M. The effects of vitamin E on the intensity of `primary dysmenorrhea: a systematic review and meta-analysis. Clin Nutr ESPEN. 2022;52:50–59.
  • Kashanian M, Lakeh MM, Ghasemi A, Noori S. Evaluation of the effect of vitamin E on pelvic pain reduction in women suffering from primary dysmenorrhea. J Reprod Med. 2013;58(1–2):34–38.
  • Sadeghi N, Paknezhad F, Rashidi Nooshabadi M, Kavianpour M, Jafari Rad S, Khadem Haghighian H. Vitamin E and fish oil, separately or in combination, on treatment of primary dysmenorrhea: a double-blind, randomized clinical trial. Gynecol Endocrinol. 2018;34(9):804–808.
  • Laufer MR, Sanfilippo J, Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol. 2003;16(3 Suppl):S3–S11.
  • Hooker AB, van Moorst BR, van Haarst EP, van Ootegehem NA, van Dijken DK, Heres MH. Chronic pelvic pain: evaluation of the epidemiology, baseline demographics, and clinical variables via a prospective and multidisciplinary approach. Clin Exp Obstet Gynecol. 2013;40(4):492–498.
  • Tripoli TM, Sato H, Sartori MG, De Araujo FF, Girao MJ, Schor E. Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis. J Sex Med. 2011;8(2):497–503.
  • Allyn K, Evans S, Seidman LC, Payne LA. ”Tomorrow, I’ll Be Fine”: impacts and coping mechanisms in adolescents and young adults with primary dysmenorrhoea. J Adv Nurs. 2020;76(10):2637–2647.
  • Armour M, Parry K, Al-Dabbas MA, et al. Self-care strategies and sources of knowledge on menstruation in 12,526 young women with dysmenorrhea: a systematic review and meta-analysis. PLoS One. 2019;14(7):e0220103.
  • Balik G, Ustuner I, Kagitci M, Sahin FK. Is there a relationship between mood disorders and dysmenorrhea? J Pediatr Adolesc Gynecol. 2014;27(6):371–374.
  • Ng TP, Tan NC, Wansaicheong GK. A prevalence study of dysmenorrhoea in female residents aged 15–54 years in Clementi Town, Singapore. Ann Acad Med Singap. 1992;21(3):323–327.
  • Alonso C, Coe CL. Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women. Health Psychol. 2001;20(6):411–416.
  • Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol. 1990;97(7):588–594.
  • Pullon S, Reinken J, Sparrow M. Prevalence of dysmenorrhoea in Wellington women. N Z Med J. 1988;101(839):52–54.
  • Weissman AM, Hartz AJ, Hansen MD, Johnson SR. The natural history of primary dysmenorrhoea: a longitudinal study. BJOG. 2004;111(4):345–352.
  • Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics. 1981;68(5):661–664.
  • Woosley JA, Lichstein KL. Dysmenorrhea, the menstrual cycle, and sleep. Behav Med. 2014;40(1):14–21.
  • Bahrami A, Sadeghnia H, Avan A, et al. Neuropsychological function in relation to dysmenorrhea in adolescents. Eur J Obstet Gynecol Reprod Biol. 2017;215:224–229.
  • Gallagher JS, DiVasta AD, Vitonis AF, Sarda V, Laufer MR, Missmer SA. The impact of endometriosis on quality of life in adolescents. J Adolesc Health. 2018;63(6):766–772.
  • Gagua T, Tkeshelashvili B, Gagua D. Primary dysmenorrhea: prevalence in adolescent population of Tbilisi, Georgia and risk factors. J Turk Ger Gynecol Assoc. 2012;13(3):162–168.
  • Granot M, Yarnitsky D, Itskovitz-Eldor J, Granovsky Y, Peer E, Zimmer EZ. Pain perception in women with dysmenorrhea. Obstet Gynecol. 2001;98(3):407–411.
  • Bajalan Z, Moafi F, MoradiBaglooei M, Alimoradi Z. Mental health and primary dysmenorrhea: a systematic review. J Psychosom Obstet Gynaecol. 2019;40(3):185–194.
  • Jones AV, Hockley JRF, Hyde C, et al. Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus. Pain. 2016;157(11):2571–2581.
  • Ju H, Jones M, Mishra GD. A U-Shaped relationship between body mass index and dysmenorrhea: a longitudinal study. PLoS One. 2015;10(7):e0134187.
  • Unsal A, Ayranci U, Tozun M, Arslan G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci. 2010;115(2):138–145.
  • Pejcic A, Jankovic S. Risk factors for dysmenorrhea among young adult female university students. Ann Ist Super Sanita. 2016;52(1):98–103.
  • Nur Azurah AG, Sanci L, Moore E, Grover S. The quality of life of adolescents with menstrual problems. J Pediatr Adolesc Gynecol. 2013;26(2):102–108.
  • Hennegan J, OlaOlorun FM, Oumarou S, et al. School and work absenteeism due to menstruation in three West African countries: findings from PMA2020 surveys. Sex Reprod Health Matters. 2021;29(1):1915940.
  • Yesuf TA, Eshete NA, Sisay EA. Dysmenorrhea among university health science students, northern Ethiopia: impact and associated factors. Int J Reprod Med. 2018;2018:9730328.
  • Rencz F, Pentek M, Stalmeier PFM, et al. Bleeding out the quality-adjusted life years: evaluating the burden of primary dysmenorrhea using time trade-off and willingness-to-pay methods. Pain. 2017;158(11):2259–2267.
  • Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y. Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database. Clinicoecon Outcomes Res. 2017;9:295–306.
  • Chen I, Thavorn K, Shen M, et al. Hospital-associated costs of chronic pelvic pain in Canada: a population-based descriptive study. J Obstet Gynaecol Can. 2017;39(3):174–180.
  • Li R, Li B, Kreher DA, Benjamin AR, Gubbels A, Smith SM. Association between dysmenorrhea and chronic pain: a systematic review and meta-analysis of population-based studies. Am J Obstet Gynecol. 2020;223(3):350–371.
  • Missmer SA, Tu FF, Agarwal SK, et al. Impact of endometriosis on life-course potential: a narrative review. Int J Gen Med. 2021;14:9–25.
  • Burton-Jeangros C, Cullati S, Sacker A, Blane D. Introduction. In: Burton-Jeangros C, Cullati S, Sacker A, Blane D, editors. A Life Course Perspective on Health Trajectories and Transitions. Cham (CH); 2015:1–18.
  • Ambresin AE, Belanger RE, Chamay C, Berchtold A, Narring F. Body dissatisfaction on top of depressive mood among adolescents with severe dysmenorrhea. J Pediatr Adolesc Gynecol. 2012;25(1):19–22.
  • Sahin N, Kasap B, Kirli U, Yeniceri N, Topal Y. Assessment of anxiety-depression levels and perceptions of quality of life in adolescents with dysmenorrhea. Reprod Health. 2018;15(1):13.
  • Eryilmaz G, Ozdemir F, Pasinlioglu T. Dysmenorrhea prevalence among adolescents in eastern Turkey: its effects on school performance and relationships with family and friends. J Pediatr Adolesc Gynecol. 2010;23(5):267–272.
  • Liu P, Liu Y, Wang G, et al. Changes of functional connectivity of the anterior cingulate cortex in women with primary dysmenorrhea. Brain Imaging Behav. 2018;12(3):710–717.
  • Wong LP, Khoo EM. Dysmenorrhea in a multiethnic population of adolescent Asian girls. Int J Gynaecol Obstet. 2010;108(2):139–142.
  • Zannoni L, Giorgi M, Spagnolo E, Montanari G, Villa G, Seracchioli R. Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol. 2014;27(5):258–265.
  • Al-Jefout M, Seham AF, Jameel H, et al. Dysmenorrhea: prevalence and impact on quality of life among young adult Jordanian females. J Pediatr Adolesc Gynecol. 2015;28(3):173–185.
  • Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med. 2000;154(12):1226–1229.
  • Sommer M, Schmitt M, Gruer C, Herbert A, Phillips-Howard P. Neglect of menarche and menstruation in the USA. Lancet. 2019;393(10188):2302.
  • Bush D, Brick E, East MC, Johnson N. Endometriosis education in schools: a New Zealand model examining the impact of an education program in schools on early recognition of symptoms suggesting endometriosis. Aust N Z J Obstet Gynaecol. 2017;57(4):452–457.